Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 SCM Pharma Names BD Director | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

SCM Pharma Names BD Director

Bellamy brings 30 years of experience

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Simon Bellamy has been appointed business development director at SCM Pharma. Mr. Bellamy will be responsible for new clinical trials business and small commercial opportunities for the company’s new $10 million facility in Newburn. He has 30 years of experience in the pharmaceutical industry. Most recently he held business development roles at Catalent Pharma Solutions and Piramal Healthcare.
 
Dianne Sharp, managing director at SCM Pharma, said, “Attracting Simon to our business is a major coup given his past experience in the contract manufacturing arena and he will no doubt add a huge amount of value to our exciting growth plans. We now have two of the finest sterile filling facilities in Europe catering for development, clinical trial projects and commercial supply, which gives Simon and his team a compelling service offering to take to the market.”
 
SCM Pharma specializes in the sterile production of products for clinical trials along with the supply of licensed drugs in niche markets. Its new facility completed a successful inspection from the MHRA this past summer.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics